Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results
Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease.
A Controversial Alzheimer’s Drug Has Gone Down in Flames
Cassava Sciences' simufilam failed a Phase III trial for Alzheimer's disease, likely marking the end of a drug surrounded by allegations of poorly done and fraudulent research.
Controversial Alzheimer's drug trial halted
The trial, which involved patients with mild-to-moderate Alzheimer's disease, failed to show significant improvement in cognition and daily functioning compared to a placebo after 52 weeks, according to a Nov.
7h
on MSN
'Alzheimer's in dish' model shows promise for accelerating drug discovery
A decade ago, researchers introduced a new model for studying Alzheimer's disease. Known as "Alzheimer's in a dish," the ...
2d
on MSN
Cassava shares sink on plans to stop Alzheimer's drug studies
(Reuters) -Cassava Sciences said it will stop all trials of its Alzheimer's disease drug after it failed a late-stage study, ...
1d
Alzheimer's awareness: 10 early warning signs, 10 healthy habits
Stay alert with list of early signs and symptoms of dementia that disrupts daily life and may be a symptom of Alzheimer’s or ...
Fox 9
1h
Sen. Klobuchar hosts Alzheimer’s support legislation press conference
On Wednesday, Sen. Amy Klobuchar held an event highlighting legislation passed to support families who care for people living ...
2d
on MSN
Cassava's Alzheimer's drug fails in late-stage study
(Reuters) -Cassava Sciences on Monday said its experimental Alzheimer's disease drug did not meet the main or secondary goals ...
Science Daily
1h
New discovery could offer significant answers on Alzheimer's disease
A new study represents a significant step forward in scientists' understanding of Alzheimer's disease. A team of investigators has examined the role of two proteins found in the brain and suggest the ...
FierceBiotech
1d
UPDATED: Alector lays off 17% of staff after AbbVie-partnered Alzheimer's asset fails phase 2
Alector’s AbbVie-partnered Alzheimer's asset has failed to slow disease progression in a phase 2 study, the latest in a ...
1d
Alzheimer’s disease: toxic protein is turned bad by immune enzyme, mouse study shows
Tau behaves abnormally in the brain in people with Alzheimer’s disease. This latest study points to a reason why.
Psychology Today
1d
The Relationship Between Music and Alzheimer’s Disease
Alzheimer’s is the most common type of dementia. Music therapy can improve mood and cognitive performance in Alzheimer’s ...
McKnight's Senior Living
17h
California notes progress in Alzheimer’s support plans, looks toward dementia-capable continuum of care
Guided by the Alzheimer's Disease Prevention and Preparedness Task Force, California has taken “significant” action and made ...
KTNV Las Vegas
23h
National Alzheimer’s Awareness Month highlights financial risks for seniors
LAS VEGAS (KTNV) — November is National
Alzheimer
’s Awareness Month, and this year, experts are shining a light on a ...
Hosted on MSN
1d
Alzheimer's Trials Fail; Blood Test Predicts Tau; Neuroscience Moves to Bluesky
Investigational simufilam failed to reduce cognitive or functional decline in Alzheimer's disease patients in the ReThink-ALZ ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Cassava
Alector
simufilam
Feedback